Jan 27, 2021
Claudia Christian of FHI Clinical discusses Covid-19 impact on Clinical Trials. The challenge of patient recruitment in Clinical Trials
Claudia Christian is the Senior Vice President, Clinical Operations of FHI Clinical. FHI Clinical has, among other things provided clinical operations services for ACTT-1 trial...
Jan 20, 2021
We sit down and talk to Dr. Abribat about Amolyt Pharma, which is developing therapeutic peptides to treat rare endocrine and metabolic diseases. The company recently announced that it has dosed the first patient in a Phase 1 clinical trial evaluating its experimental therapeutic peptide, AZP-3601, for a...
Jan 13, 2021
Dr. David Horn Solomon, CEO of Pharnext discusses PXT3003 which
is currently focused on the treatment of Charcot Marie-Tooth (CMT)
disease Type 1A.
Charcot-Marie-Tooth is a degenerative nerve disease that usually
appears in adolescence or early adulthood. CMT affects the
Peripheral Nervous System. It is a progressive...
Jan 6, 2021
Dr. Lenze discusses a clinical trial conducted by Washington University School of Medicine in St. Louis which evidences the potential that fluvoxamine, an antidepressant, may prevent COVID-19 infections from worsening. This trial is based on recent research that originates from the University of Virginia School...